IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion

English version České info

Interferon-induced transmembrane proteins (IFITMs) block infection of many enveloped viruses, including the influenza A virus (IAV) that enters from late endosomes. IFITMs are thought to prevent virus hemifusion (merger of contacting leaflets without formation of a fusion pore) by altering the properties of cell membranes. Here we performed single IAV imaging and found that IFITM3 did not interfere with hemifusion, but prevented complete fusion. Also, contrary to a current view that excess cholesterol in late endosomes of IFITM3-expressing cells inhibits IAV entry, we show that cholesterol-laden endosomes are permissive for virus fusion. The ability of IFITM3 to block the formation of fusion pores implies that this protein stabilizes the cytoplasmic leaflet of endosomal membranes, either directly or indirectly, through altering its physical properties. IFITM3 may also redirect IAV to a non-productive pathway by promoting fusion with intralumenal vesicles of late endosomes instead of their limiting membrane.

Vyšlo v časopise: IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion. PLoS Pathog 10(4): e32767. doi:10.1371/journal.ppat.1004048
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004048

Souhrn

Zdroje

1. DiamondMS, FarzanM (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13: 46–57.

2. BrassAL, HuangIC, BenitaY, JohnSP, KrishnanMN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243–1254.

3. PerreiraJM, ChinCR, FeeleyEM, BrassAL (2013) IFITMs Restrict the Replication of Multiple Pathogenic Viruses. J Mol Biol 425: 4937–55 doi:10.1016/j.jmb.2013.09.024

4. MudhasaniR, TranJP, RettererC, RadoshitzkySR, KotaKP, et al. (2013) IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87: 8451–8464.

5. LiK, MarkosyanRM, ZhengYM, GolfettoO, BungartB, et al. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9: e1003124.

6. HuangIC, BaileyCC, WeyerJL, RadoshitzkySR, BeckerMM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258.

7. JiangD, WeidnerJM, QingM, PanXB, GuoH, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84: 8332–8341.

8. BaileyCC, HuangIC, KamC, FarzanM (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 8: e1002909.

9. EverittAR, ClareS, PertelT, JohnSP, WashRS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519–523.

10. EverittAR, ClareS, McDonaldJU, KaneL, HarcourtK, et al. (2013) Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8: e80723.

11. ChutiwitoonchaiN, HiyoshiM, Hiyoshi-YoshidomiY, HashimotoM, TokunagaK, et al. (2013) Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect 15: 280–290.

12. LuJ, PanQ, RongL, HeW, LiuSL, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126–2137.

13. FeeleyEM, SimsJS, JohnSP, ChinCR, PertelT, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337.

14. Amini-Bavil-OlyaeeS, ChoiYJ, LeeJH, ShiM, HuangIC, et al. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13: 452–464.

15. JohnSP, ChinCR, PerreiraJM, FeeleyEM, AkerAM, et al. (2013) The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 87: 7837–7852.

16. YountJS, MoltedoB, YangYY, CharronG, MoranTM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610–614.

17. BaileyCC, KondurHR, HuangIC, FarzanM (2013) Interferon-Induced Transmembrane Protein 3 is a Type II Transmembrane Protein. J Biol Chem 288 doi:10.1074/jbc.M113.514356

18. SieczkarskiSB, WhittakerGR (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4: 333–343.

19. BolardJ (1986) Interaction of polyene antibiotics with membrane lipids: physicochemical studies of the molecular basis of selectivity. Drugs Exp Clin Res 12: 613–618.

20. LinTY, ChinCR, EverittAR, ClareS, PerreiraJM, et al. (2013) Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep 5: 895–908.

21. RojekJM, SanchezAB, NguyenNT, de la TorreJC, KunzS (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82: 7677–7687.

22. BeerC, AndersenDS, RojekA, PedersenL (2005) Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J Virol 79: 10776–10787.

23. CavroisM, De NoronhaC, GreeneWC (2002) A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20: 1151–1154.

24. MiyauchiK, KimY, LatinovicO, MorozovV, MelikyanGB (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433–444.

25. TscherneDM, ManicassamyB, Garcia-SastreA (2010) An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods 163: 336–343.

26. ChernomordikLV, KozlovMM (2005) Membrane hemifusion: crossing a chasm in two leaps. Cell 123: 375–382.

27. CohenFS, MelikyanGB (2004) The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol 199: 1–14.

28. LakadamyaliM, RustMJ, BabcockHP, ZhuangX (2003) Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100: 9280–9285.

29. van der SchaarHM, RustMJ, WaartsBL, van der Ende-MetselaarH, KuhnRJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019–12028.

30. MelikyanGB, WhiteJM, CohenFS (1995) GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol 131: 679–691.

31. NourAM, LiY, WolenskiJ, ModisY (2013) Viral Membrane Fusion and Nucleocapsid Delivery into the Cytoplasm are Distinct Events in Some Flaviviruses. PLoS Pathog 9: e1003585.

32. LowyRJ, SarkarDP, ChenY, BlumenthalR (1990) Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci U S A 87: 1850–1854.

33. RubinRJ, ChenYD (1990) Diffusion and redistribution of lipid-like molecules between membranes in virus-cell and cell-cell fusion systems. Biophys J 58: 1157–1167.

34. TseFW, IwataA, AlmersW (1993) Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J Cell Biol 121: 543–552.

35. ChernomordikLV, FrolovVA, LeikinaE, BronkP, ZimmerbergJ (1998) The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140: 1369–1382.

36. FloydDL, RagainsJR, SkehelJJ, HarrisonSC, van OijenAM (2008) Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105: 15382–15387.

37. Padilla-ParraS, MarinM, GahlautN, SuterR, KondoN, et al. (2013) Fusion of Mature HIV-1 Particles Leads to Complete Release of a Gag-GFP-Based Content Marker and Raises the Intraviral pH. PLoS ONE 8: e71002.

38. KohCH, CheungNS (2006) Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 18: 1844–1853.

39. MukherjeeS, MaxfieldFR (2004) Lipid and cholesterol trafficking in NPC. Biochim Biophys Acta 1685: 28–37.

40. CaretteJE, RaabenM, WongAC, HerbertAS, ObernostererG, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340–343.

41. CoteM, MisasiJ, RenT, BruchezA, LeeK, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344–348.

42. LafourcadeC, SoboK, Kieffer-JaquinodS, GarinJ, van der GootFG (2008) Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS ONE 3: e2758.

43. LenardJ, MillerDK (1981) pH-dependent hemolysis by influenza, Semliki, Forest virus, and Sendai virus. Virology 110: 479–482.

44. WojtanikKM, LiscumL (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278: 14850–14856.

45. ShoemakerCJ, SchornbergKL, DelosSE, ScullyC, PajouheshH, et al. (2013) Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS ONE 8: e56265.

46. BiswasS, YinSR, BlankPS, ZimmerbergJ (2008) Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin. J Gen Physiol 131: 503–513.

47. RazinkovVI, CohenFS (2000) Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus. Biochemistry 39: 13462–13468.

48. DomanskaMK, WronaD, KassonPM (2013) Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles. Biophys J 105: 1383–1387.

49. LevS (2010) Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol 11: 739–750.

50. Le BlancI, LuyetPP, PonsV, FergusonC, EmansN, et al. (2005) Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653–664.

51. PasqualG, RojekJM, MasinM, ChattonJY, KunzS (2011) Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7: e1002232.

52. JhaNK, LatinovicO, MartinE, NovitskiyG, MarinM, et al. (2011) Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. PLoS Pathog 7: e1001260.

53. MarkosyanRM, CohenFS, MelikyanGB (2000) The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell 11: 1143–1152.

54. ZimmerbergJ, BlumenthalR, SarkarDP, CurranM, MorrisSJ (1994) Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J Cell Biol 127: 1885–1894.

55. de la VegaM, MarinM, KondoN, MiyauchiK, KimY, et al. (2011) Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology 8: 99.

56. CossetFL, MarianneauP, VerneyG, GallaisF, TordoN, et al. (2009) Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol 83: 3228–3237.

57. ManicassamyB, WangJ, JiangH, RongL (2005) Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 79: 4793–4805.

58. DemirkhanyanLH, MarinM, Padilla-ParraS, ZhanC, MiyauchiK, et al. (2012) Multifaceted mechanisms of HIV-1 entry inhibition by human alpha-defensin. J Biol Chem 287: 28821–28838.